Dr. Vijay Palwe

Consultant - Radiation Oncology

Home / Our Doctors / Dr. Vijay Palwe

Consultant - Radiation Oncology

Book Appointment

Consultant - Radiation Oncology

Qualification

MBBS, MD (Radiation Oncology)16 years’ experience, PDCR (Radiation Oncology)

Experience

16 Years

Specialities

Email

with Dr. Vijay Palwe

Dr. Vijay’s expertise lies in the management of all types of malignant and benign tumours and oncological emergencies.
He is well trained in conventional, 3DCRT, IMRT and IGRT based treatments, with a special interest in head and neck cancers, breast cancers and gynaecological cancers, brachytherapy (head & neck, breast, soft tissue sarcoma, cervix, vault) SRS, SAT, SRT,SBRT, DIBH.
He has handled more than 16,000 cases so far.

Underwent training for Tomotherapy at Clinica Luganese, Lugano, Switzerland in June 2017

JRD Tata Scholarship 2001 (MBBS)
MASCC/ISOO Travel scholarship for annual meeting2010 at Vancouver, Canada (June 2010)
MASCC/ISOO Membership scholarship 2010 &2011
Certificate of Merit from MUHS (2010-2011) for success in M.D. (Radiation Oncology) Exams held in 2009.

Objective assessment of swallowing function after definitive concurrent (chemo) radiotherapy in patients with head and neck cancer (2011). Dysphagia, 26(4), 399-406.
Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation (2010) Journal of cancer research and therapeutics, 6(1), 15.
Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients (2020). European journal of breast health, 16(1), 39.
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial (2019). Oncotarget, 10(54), 5605.
The predictive role of neutrophil-to-lymphocyte ratio in the outcomes of patients with sarcomatoid carcinoma of oral cavity (2021). European Archives of Oto-Rhino-Laryngology, 1-9.
Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre (2020). Journal of Radiotherapy in Practice, 19(4), 359-364.
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience (2021). European Journal of Breast Health, 17(1), 62.